This training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.
Moving away from the standard course of IV antibiotics.
When the US Preventive Services Task Force (USPSTF) recommended that all baby boomers undergo a one-time hepatitis C screening in 2013, testing prevalence increased. However, the rate is still lower than officials would like to see.
The emergence of new species creates pressure for developing affordable and reliable diagnostic strategies.
By targeting CabA, an extracellular matrix protein essential for biofilm formation, it may be possible to reduce the incidence of food-borne illnesses caused by the potentially lethal Vibrio vulnificus marine bacterium found in biofilms on oyster shells and meat.
Implants are promising for long-term, sustained, and reversible delivery of ARV drugs that may bypass adherence challenges for end users.
The constant reassessment of business practices is necessary to ensure that practitioners are not wasting valuable time, resources, and effort on activities that are not producing the desired results.
CDI remains an urgent public health threat and continues to be the most frequent cause of diarrhea among hospitalized patients and overall hospital-acquired infection in the United States.
Readmission rates for patients receiving OPAT are reported to be as high as 20%, mostly due to catheter-related problems, adverse drug reactions, or worsening of the primary infection.
The quick Pitt Bacteremia Score offers accuracy comparable to the original version's across multiple infections, and maintains ease of use.
Quick action was needed against this very rare cause of fungal endocarditis.
The results of a new study demonstrate that PrEP can reduce new infections within a population even when the risk of HIV remains high and other proven treatment and prevention strategies are optimized.
In the last segment of the series, Jones offered his insights for when he considers discharging patients.
Despite concerning findings and warnings, fluoroquinolones have remained one of the world’s most commonly prescribed antibiotic classes, with the United States accounting for more than 32 million prescriptions in 2015 alone.
Implants are promising for long-term, sustained, and reversible delivery of ARV drugs that may bypass adherence challenges for end users.
Catheter-associated urinary tract infections (CAUTIs) account for about 40% of all nosocomial infections in hospitals and nursing homes.
Being immunocompromised increases risk of rare Mycobacterium tuberculosis epididymo-orchitis.
A patient presented with a history of uncontrolled HIV and a history of polysubstance use.
Investigators are dusting off angiotensin II and ascorbic acid for renewed use in treating sepis and septic shock.
Experts weigh in on what Congress is doing to tackle the threat of antibiotic resistance.
Expanding the differential for diarrhea beyond Clostridium difficile.
Treatment-experienced patients still have some good options.
A review of the neutralizing antibody that was studied in a phase 2/3 trial in outpatients with mild to moderate infections of COVID-19.
The story of an early-infected US physician who launched a non-profit, participated in trials, and guided her peers after overcoming infection.
In this narrative review of studies evaluating antiretroviral stewardship programs (ARVSPs), we propose core elements for ARVSPs that are based on published evidence, clinical experience, and adapted from antimicrobial stewardship programs.
Treatment with a combination of tenofovir and pegylated interferon yielded higher rates of hepatitis B surface antigen (HBsAg) loss than when either drug was used singly. Further, with longer therapy duration improved results.